![September 2023: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection](https://icap.columbia.edu/wp-content/uploads/JC-2023-photo-973x675.jpg)
Peru
![September 2023: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection](https://icap.columbia.edu/wp-content/uploads/JC-2023-photo-973x675.jpg)
Programmatic Support Award (PSA)
Building on over 15 years of partnership between ICAP at Columbia University, PEPFAR, and CDC, the Programmatic Support Award provides rapid, flexible technical support to accelerate evidence-based HIV prevention and treatment program implementation and align health...![May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis](https://icap.columbia.edu/wp-content/uploads/0-3-e1622128820264-1080x675.png)